Frontline Oral Arsenic Trioxide for APL

Clinical trial NCT04687176 · RECRUITING

Trial details

NCT number: NCT04687176
Sponsor: The University of Hong Kong
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Promyelocytic Leukemia

Start date: 2021-01-01
Primary completion: 2025-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.